These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

822 related articles for article (PubMed ID: 28288893)

  • 1. Redox-responsive theranostic nanoplatforms based on inorganic nanomaterials.
    Han L; Zhang XY; Wang YL; Li X; Yang XH; Huang M; Hu K; Li LH; Wei Y
    J Control Release; 2017 Aug; 259():40-52. PubMed ID: 28288893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theranostic applications of carbon nanomaterials in cancer: Focus on imaging and cargo delivery.
    Chen D; Dougherty CA; Zhu K; Hong H
    J Control Release; 2015 Jul; 210():230-45. PubMed ID: 25910580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetism, Ultrasound, and Light-Stimulated Mesoporous Silica Nanocarriers for Theranostics and Beyond.
    Lin FC; Xie Y; Deng T; Zink JI
    J Am Chem Soc; 2021 Apr; 143(16):6025-6036. PubMed ID: 33857372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2D Nanomaterials for Cancer Theranostic Applications.
    Cheng L; Wang X; Gong F; Liu T; Liu Z
    Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescent carbon dot modified mesoporous silica nanocarriers for redox-responsive controlled drug delivery and bioimaging.
    Jiao J; Liu C; Li X; Liu J; Di D; Zhang Y; Zhao Q; Wang S
    J Colloid Interface Sci; 2016 Dec; 483():343-352. PubMed ID: 27569517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Composition-property relationships in multifunctional hollow mesoporous carbon nanosystems for PH-responsive magnetic resonance imaging and on-demand drug release.
    Zhang S; Qian X; Zhang L; Peng W; Chen Y
    Nanoscale; 2015 May; 7(17):7632-43. PubMed ID: 25785502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery.
    Du X; Li X; Xiong L; Zhang X; Kleitz F; Qiao SZ
    Biomaterials; 2016 Jun; 91():90-127. PubMed ID: 27017579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the Use of Multifunctional Mesoporous Silica Nanoparticles and Related Nanomaterials as Carriers for the Cancer Treatment.
    Song C; Wang X; Wang Y; Yu H; Cui Y; Ma T
    Curr Drug Metab; 2018; 19(2):131-141. PubMed ID: 28758578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
    Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
    Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment.
    Yang F; Jin C; Subedi S; Lee CL; Wang Q; Jiang Y; Li J; Di Y; Fu D
    Cancer Treat Rev; 2012 Oct; 38(6):566-79. PubMed ID: 22655679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesoporous silica nanomaterial-based biotechnological and biomedical delivery systems.
    Giri S; Trewyn BG; Lin VS
    Nanomedicine (Lond); 2007 Feb; 2(1):99-111. PubMed ID: 17716196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional nanomedicine with silica: Role of silica in nanoparticles for theranostic, imaging, and drug monitoring.
    Chen F; Hableel G; Zhao ER; Jokerst JV
    J Colloid Interface Sci; 2018 Jul; 521():261-279. PubMed ID: 29510868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-guided nanomedicines as novel breakthrough therapeutic, diagnostic and theranostic tools.
    Farahavar G; Abolmaali SS; Gholijani N; Nejatollahi F
    Biomater Sci; 2019 Oct; 7(10):4000-4016. PubMed ID: 31355391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Light-Induced Hydrogel Based on Tumor-Targeting Mesoporous Silica Nanoparticles as a Theranostic Platform for Sustained Cancer Treatment.
    Chen X; Liu Z; Parker SG; Zhang X; Gooding JJ; Ru Y; Liu Y; Zhou Y
    ACS Appl Mater Interfaces; 2016 Jun; 8(25):15857-63. PubMed ID: 27265514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inorganic Nanomaterials as Carriers for Drug Delivery.
    Chen S; Hao X; Liang X; Zhang Q; Zhang C; Zhou G; Shen S; Jia G; Zhang J
    J Biomed Nanotechnol; 2016 Jan; 12(1):1-27. PubMed ID: 27301169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gold Nanosphere Gated Mesoporous Silica Nanoparticle Responsive to Near-Infrared Light and Redox Potential as a Theranostic Platform for Cancer Therapy.
    Cheng B; He H; Huang T; Berr SS; He J; Fan D; Zhang J; Xu P
    J Biomed Nanotechnol; 2016 Mar; 12(3):435-49. PubMed ID: 26949379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optically active organic and inorganic nanomaterials for biological imaging applications: A review.
    Sowmiya P; Dhas TS; Inbakandan D; Anandakumar N; Nalini S; Suganya KSU; Remya RR; Karthick V; Kumar CMV
    Micron; 2023 Sep; 172():103486. PubMed ID: 37262930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicines for Renal Management: From Imaging to Treatment.
    Jiang D; Rosenkrans ZT; Ni D; Lin J; Huang P; Cai W
    Acc Chem Res; 2020 Sep; 53(9):1869-1880. PubMed ID: 32786331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smart multifunctional drug delivery towards anticancer therapy harmonized in mesoporous nanoparticles.
    Baek S; Singh RK; Khanal D; Patel KD; Lee EJ; Leong KW; Chrzanowski W; Kim HW
    Nanoscale; 2015 Sep; 7(34):14191-216. PubMed ID: 26260245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shape matters when engineering mesoporous silica-based nanomedicines.
    Hao N; Li L; Tang F
    Biomater Sci; 2016 Apr; 4(4):575-91. PubMed ID: 26818852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.